- Home
- CANF vs MEGL Comparison
CANF vs MEGL Comparison
Compare CANF & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CANF | MEGL |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | Israel | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 5.8M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CANF | MEGL |
|---|---|---|
| Price | $3.37 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | ★ 21.6K | 11.3K |
| Earning Date | 03-26-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,715,455.50 | N/A |
| Revenue Next Year | $101.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $0.87 |
| 52 Week High | $10.40 | $1.90 |
Technical Indicators
Market Signals| Indicator | CANF | MEGL |
|---|---|---|
| Relative Strength Index (RSI) | 50.19 | 46.39 |
| Support Level | $3.18 | $1.16 |
| Resistance Level | $3.60 | $1.39 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 39.02 | 20.83 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The company's offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.